• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pipeline

Pipeline

February 11, 2019
Company Drug/Device Medical Condition Status
AtriCure, Inc. cryoICE Ablation System atrial fibrillation (Afib) Phase I trial initiated enrolling up to 150 subjects at up to 20 centers in the U.S. with persistent and long-standing persistent atrial fibrillation undergoing cardiac surgical procedure(s) for heart valve repair or replacement and/or coronary artery bypass procedures
Verseon VE-1902 coronary artery disease Phase I trial initiated enrolling 100-120 healthy volunteers
Actinium Pharmaceuticals, Inc. Actimab-A and venetoclax Acute Myeloid Leukemia (AML) Phase I/II trial initiated enrolling subjects with relapsed or refractory AML that have been previously treated with venetoclax and subjects that have never received venetoclax
Orphan Technologies OT-58 classical homocystinuria Phase II trial initiated enrolling up to 20 subjects
Neurana Pharmaceuticals tolperisone acute muscle spasms of the back Phase II trial initiated enrolling 400 subjects
BioLineRx Ltd. BL-8040 pancreatic cancer Orphan Drug Designation granted by the FDA
REGENXBIO, Inc. RGX-181 late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2)
disease
Rare Pediatric Disease Designation granted
by the FDA
Pharnext SA PXT3003 Charcot-Marie-Tooth disease Type 1A (CMT1A) Fast Track Designation granted by the FDA
Teleflex Incorporated MANTA Vascular Closure Device large bore femoral arterial access site closure PMA granted by the FDA
Flowonix Medical, Inc. Flowonix Maestro Software for Clinician Programmers used to program Prometra Pump Systems intrathecal infusion
of drug therapy
Approval granted by the FDA
Cook Medical Zenith Dissection Endovascular System Type B dissections of the descending thoracic aorta Approval granted by the FDA
Mylan N.V. generic Advair Diskus (fluticasone propionate and salmeterol inhalation powder) twice-daily treatment of asthma in patients aged four years and older and maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD) Approval granted by the FDA

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing